SYNERGENE

Synergene Active Ingredients Private Limited, incorporated in 2006, manufactures and supplies active pharmaceutical ingredients (APIs), intermediates and personal care ingredients, and is one of the leading world manufacturers of Terbinafine Hydrochloride, Fluconazole, Voriconazole, Losartan Potassium and Escitalopram Oxalate. Synergene's Unit II in Visakhapatnam was inspected and approved by Japan's PMDA in 2023, and by USFDA and ANVISA in 2024.